Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Bluebird Names Katherine Breedis As Interim CFO

Bluebird Names Katherine Breedis As Interim CFO

-SEC Filing

byBenzinga Newsdesk

September 23, 2022

1 minute read

-SEC Filing

PaxMedica’s Successful Trial Paves the Way For First US-Approved Drug For African Sleepiness

By Vandana Singh

July 24, 11:06 AM

PaxMedica Inc (NASDAQ: PXMD) shares are trading higher after the company released topline data from PAX-HAT-301 Retrospective Analysis of Suramin Treatment for Stage 1 Trypanosoma Brucei Rhodesiense Human African

PXMD

Why XPeng Stock Is Accelerating Higher Today

By Adam Eckert

April 17, 8:56 AM

XPeng Inc (NYSE: XPEV) shares are trading higher Monday after the company launched a new platform which will cut its R&D cycle by 20%.

XPEV

Raymond James Maintains Market Perform on Magna International, Lowers Price Target to $56

By Benzinga Newsdesk

February 13, 8:33 AM

Raymond James analyst Michael Glen maintains Magna International (NYSE:MGA) with a Market Perform and lowers the price target from $62 to $56.

MGA

Another 10-Year Deal: Microsoft Extends Partnership With UK’s EE

By Franca Quarneti

April 11, 3:39 PM

Phil Spencer, the head of Microsoft Corp.'s (NASDAQ: MSFT) Xbox, announced that the tech giant signed another 10-year partnership, this time, with BT Group's (OTC: BTGOF)

ATVI

Bluebird Names Katherine Breedis As Interim CFO

Related Posts

PaxMedica’s Successful Trial Paves the Way For First US-Approved Drug For African Sleepiness

Why XPeng Stock Is Accelerating Higher Today

Raymond James Maintains Market Perform on Magna International, Lowers Price Target to $56

Another 10-Year Deal: Microsoft Extends Partnership With UK’s EE